Comparisons9 min readUpdated 2026-04-10

    Found Semaglutide Review: Cost, Coaching, and What Patients Should Compare

    Read a practical Found semaglutide review covering pricing structure, coaching, medication access, and what to weigh before choosing a provider.

    Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH.

    Quick Answer

    Found is a real medical weight-loss platform with coaching, multiple plan types, and semaglutide-related treatment pathways. The better question is whether that structure feels clear enough and simple enough for the kind of semaglutide experience you want.

    Why This Search Matters

    Review terms usually come late in the funnel. By the time a user searches this, they often already know Found exists and want a final trust check. Most readers want to know whether Found is legitimate, how hard the plan structure is, what the real monthly cost feels like, and whether the support experience feels worth it.

    What Found Does Well

    Found has a clear weight-loss identity and publicly leans into coaching, app support, and clinical guidance. It also markets multiple care paths, including branded GLP-1 and compounded GLP-1 routes.

    Where Some Readers Hesitate

    The same structure can create uncertainty. Readers may find pricing layered, plan types hard to compare, or may want more coaching or more simplicity. These issues often matter more than the headline offer.

    Bottom Line

    Found is a credible option in online weight loss, but the strongest Found semaglutide review helps readers judge plan complexity, cost clarity, and long-term fit. The more a reader wants simplicity and directness, the more alternatives belong in the comparison.

    Frequently Asked Questions

    Is Found good for semaglutide?

    Found is a real medical weight-loss platform with coaching, multiple plan types, and semaglutide-related treatment pathways. The question is whether the structure feels clear enough and simple enough for your needs.

    How much does Found semaglutide cost?

    Found uses different pricing structures depending on the plan type. Insurance-supported plans, branded GLP-1 plans, and compounded plans all have different cost structures. Understanding which applies to you is essential.

    Does Found include coaching?

    Yes. Found publicly leans into coaching, app support, and clinical guidance. Whether that adds value depends on how much structured support you want.

    Is Found semaglutide worth it?

    Worth it means the provider feels legitimate, the pricing path is understandable, the support feels useful, and the ongoing experience looks sustainable. Compare these factors before deciding.

    Who is Found best for?

    Found may fit readers who want coaching built into the process, like a structured app-based weight-loss model, and are comfortable comparing multiple plan pathways.

    Who might prefer Trimi over Found?

    Trimi is a better fit for readers who want a simpler decision path, care more about treatment clarity than program structure, and want a more direct next step.

    How do I compare semaglutide providers?

    Compare plan complexity, cost clarity, coaching value, and long-term fit. The more you want simplicity and directness, the more alternatives deserve consideration.

    Sources & References

    1. Found insurance page.
    2. Found benefits page.
    3. Found offer terms.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, adjusting, or discontinuing any medication. Individual results vary. Semaglutide and tirzepatide require a prescription and should only be used under medical supervision.

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 8, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Noom Med compounded semaglutide pricing 2026: ~$149/mo including coaching access. Detailed program review covering pharmacy partner, clinician model, dose flexibility, and how Trimi's $99/mo flat-price compounded alternative compares.

    Mochi Health semaglutide costs $178/month ($79 membership + $99 medication). Compare dosing, delivery, sublingual vs injectable options, and why Trimi delivers equivalent care at $99/month all-in.

    Detailed review of Ro's semaglutide program in 2026. Compare Ro's compounded semaglutide pricing, delivery speed, provider quality, and results to Trimi's $99/mo program.

    Compare Wegovy and compounded semaglutide side by side: pricing, effectiveness, safety, and availability in 2026. Find out which option saves you more without sacrificing quality.

    Start your GLP-1 journey — from $99/mo

    Get Started